Stay updated on Emactuzumab and Atezolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.

Latest updates to the Emactuzumab and Atezolizumab Combination Clinical Trial page
- Check2 days agoChange DetectedThe page revision label changed from v3.3.3 to v3.3.4, a minor technical update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study locations section was updated to include Connecticut, Massachusetts, New York, and Navarre, and the prior location blocks for these areas were removed; the page revision updated to v3.3.3.SummaryDifference0.5%

- Check45 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.1%

- Check52 days agoChange DetectedPublication descriptions were updated to indicate that PubMed entries are automatically filled in from PubMed and may not be about the study, and the revision tag was updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe government funding status notice banner was removed; the study details page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedMinor user-interface adjustments to the Study Details page (e.g., layout and styling changes) with no changes to the study content or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Emactuzumab and Atezolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emactuzumab and Atezolizumab Combination Clinical Trial page.